Asacol suppository (mesalazine rectal suppository) / AbbVie - LARVOL DELTA

Oral 5-Aminosalicylate, Mesalamine Suppository, and Mesalamine Enema as Initial Therapy for Ulcerative Proctitis in Clinical Practice with Quality of Care Implications. (PubMed) - Can J Gastroenterol Hepatol - "Treatment escalation was common, and total costs of therapy were higher, in patients who initiated treatment with oral 5-ASA. Further study is necessary to assess the significance of these observations."

Journal • Biosimilar • Crohn's disease • Immunology • Inflammatory Bowel Disease

Allergan to pay $2.7m to settle antitrust suit over Asacol (LSIPR) - "A subsidiary of Irish pharmaceutical company Allergan is to pay a combined total of $2.7 million to three organisations that were part of an antitrust class against the drugmaker."

Corporate lawsuit

Allergan beats class certification appeal in Asacol case for now (Bloomberg Law) - "The U.S. Court of Appeals for the First Circuit rejected the petition for a mid-case appeal by the pension funds. Their antitrust lawsuit accuses Allergan of reaching 'reverse payment' patent settlements with Zydus Pharmaceuticals USA Inc. and its parent Cadila Healthcare Ltd. over Asacol, a colitis drug."

Corporate lawsuit